BioNexus Stock Pops As It Embraces Ethereum-Focused Treasury Strategy, Says It Is First On Nasdaq To Do So

Medical technology company BioNexus Gene Lab Corp. (NASDAQ:BGLC) announced the adoption of Ethereum (CRYPTO: ETH) as a treasury reserve asset on Wednesday, following the cryptocurrency’s inclusion in the U.S. strategic reserve.

What Happened: The company’s board approved the new Ethereum-focused treasury strategy, according to a press release.

“This decision marks BGLC as the first Nasdaq-listed company to exclusively prioritize Ethereum as a strategic treasury asset, and is in line with recent announcements of Ethereum being included in the U.S. “Crypto Strategic Reserve,” BioNexus said.

See Also: El Salvador’s Nayib Bukele Defiant Amid IMF’s Bitcoin Accumulation Concerns: ‘It Won’t Stop Now, And It Won’t Stop In The …

Full story available on Benzinga.com